PROPOXYCAINE

US Previously Marketed

First approved in 1952

Details

Stereochemistry	ACHIRAL
Molecular Formula	C16H26N2O3
Molecular Weight	294.3892
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CCCOC1=C(C=CC(N)=C1)C(=O)OCCN(CC)CC

InChI

InChIKey=CAJIGINSTLKQMM-UHFFFAOYSA-N

InChI=1S/C16H26N2O3/c1-4-10-20-15-12-13(17)7-8-14(15)16(19)21-11-9-18(5-2)6-3/h7-8,12H,4-6,9-11,17H2,1-3H3

HIDE SMILES / InChI

Molecular Formula	C16H26N2O3
Molecular Weight	294.3892
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: http://pubchem.ncbi.nlm.nih.gov/compound/11078

Propoxycaine hydrochloride is a local anesthetic of the ester type that has a rapid onset of action and a longer duration of action than procaine hydrochloride. Propoxycaine Hydrochloride is the hydrochloride salt form of propoxycaine, a para-aminobenzoic acid ester. Propoxycaine binds to and inhibits voltage-gated sodium channels, thereby inhibiting the ionic flux required for the initiation and conduction of impulses. This results in a loss of sensation.

Originator

Approval Year

Conditions

Condition	Modality	Targets	Highest Phase	Product
Pain 614 Sources: http://jada.ada.org/article/S0002-8177(55)11004-2/abstract	Palliative		Approved 8429	Unknown Approved Use Propoxycaine

Overview

CYP3A4	CYP2C9	CYP2D6	hERG
inhibitor 1587	inhibitor 1767	inhibitor 1852

OverviewOther

Other Inhibitor	Other Substrate	Other Inducer
CYP1A2 1524 CYP2C19 1478

Drug as perpetrator

Target	Modality	Activity
CYP2C19 1553	inhibitor 3277 Sources: https://www.ebi.ac.uk/chembl/g/#browse/activities/full_state/eyJsaXN0Ijp7InNldHRpbmdzX3BhdGgiOiJFU19JTkRFWEVTX05PX01BSU5fU0VBUkNILkFDVElWSVRZIiwiY3VzdG9tX3F1ZXJ5IjoidGFyZ2V0X2NoZW1ibF9pZDpDSEVNQkwzNjIyIiwidXNlX2N1c3RvbV9xdWVyeSI6dHJ1ZSwic2VhcmNoX3Rlcm0iOiIiLCJ0ZXh0X2ZpbHRlciI6IkNIRU1CTDExOTUifX0%3D	no [Activation >10 uM]
CYP2C9 1819	inhibitor 3277 Sources: https://www.ebi.ac.uk/chembl/g/#browse/activities/full_state/eyJsaXN0Ijp7InNldHRpbmdzX3BhdGgiOiJFU19JTkRFWEVTX05PX01BSU5fU0VBUkNILkFDVElWSVRZIiwiY3VzdG9tX3F1ZXJ5IjoidGFyZ2V0X2NoZW1ibF9pZDpDSEVNQkwzMzk3IiwidXNlX2N1c3RvbV9xdWVyeSI6dHJ1ZSwic2VhcmNoX3Rlcm0iOiIiLCJ0ZXh0X2ZpbHRlciI6IkNIRU1CTDExOTUifX0%3D	no [Activation >10 uM]
CYP3A4 1925	inhibitor 3277 Sources: https://www.ebi.ac.uk/chembl/g/#browse/activities/full_state/eyJsaXN0Ijp7InNldHRpbmdzX3BhdGgiOiJFU19JTkRFWEVTX05PX01BSU5fU0VBUkNILkFDVElWSVRZIiwiY3VzdG9tX3F1ZXJ5IjoidGFyZ2V0X2NoZW1ibF9pZDpDSEVNQkwzNDAiLCJ1c2VfY3VzdG9tX3F1ZXJ5Ijp0cnVlLCJzZWFyY2hfdGVybSI6IiIsInRleHRfZmlsdGVyIjoiQ0hFTUJMMTE5NSJ9fQ%3D%3D	no [Activation >10 uM]
CYP2D6 1891	inhibitor 3277 Sources: https://www.ebi.ac.uk/chembl/g/#browse/activities/full_state/eyJsaXN0Ijp7InNldHRpbmdzX3BhdGgiOiJFU19JTkRFWEVTX05PX01BSU5fU0VBUkNILkFDVElWSVRZIiwiY3VzdG9tX3F1ZXJ5IjoidGFyZ2V0X2NoZW1ibF9pZDpDSEVNQkwyODkiLCJ1c2VfY3VzdG9tX3F1ZXJ5Ijp0cnVlLCJzZWFyY2hfdGVybSI6IiIsInRleHRfZmlsdGVyIjoiQ0hFTUJMMTE5NSJ9fQ%3D%3D	yes [Activation 1.99526 uM]
CYP1A2 1692	inhibitor 3277 Sources: https://www.ebi.ac.uk/chembl/g/#browse/activities/full_state/eyJsaXN0Ijp7InNldHRpbmdzX3BhdGgiOiJFU19JTkRFWEVTX05PX01BSU5fU0VBUkNILkFDVElWSVRZIiwiY3VzdG9tX3F1ZXJ5IjoidGFyZ2V0X2NoZW1ibF9pZDpDSEVNQkwzMzU2IiwidXNlX2N1c3RvbV9xdWVyeSI6dHJ1ZSwic2VhcmNoX3Rlcm0iOiIiLCJ0ZXh0X2ZpbHRlciI6IkNIRU1CTDExOTUifX0%3D	yes [Activation 12.58925 uM]

Sourcing

Vendor/Aggregator	ID	URL
AK Scientific, Inc. (AKSCI)	Y4376	http://www.aksci.com/item_detail.php?cat=Y4376
Ambinter	Amb22734490	http://www.ambinter.com/reference/22734490
BLD Pharm	BD149274	http://www.bldpharm.com/products/86-43-1.html
BioSynth	J-506353	https://www.biosynth.com/en/products/all-products/products/J-506353.html
ChemMol	99169233	http://www.chemmol.com/chemmol/99169233.html
Matrix Scientific	188763	https://www.matrixscientific.com/188763.html
OChem	30695	http://www.ocheminc.com/index.php?act=psearch&pid=550P834
Renno Tech	RP06763	http://www.rennotech.com/product_show.asp?id=13182
Sigma-Aldrich	CDS021586_ALDRICH	https://www.sigmaaldrich.com/catalog/product/aldrich/cds021586?utm_source=pubchem&utm_campaign=pubchem_2017&utm_medium=referral
Smolecule	S588041	https://www.smolecule.com/products/s588041
THE BioTek	bt-374334	https://www.thebiotek.com/product/others/bt-374334
abcr GmbH	AB444846	http://www.abcr.com/shop/en/AB444846
eNovation Chemicals	D205911	https://www.enovationchem.com/ProductDetails.asp?ProductID=D205911

PubMed

Title	Date	PubMed
Does instilling proxymetacaine before cyclopentolate significantly reduce stinging? The implications of paediatric cycloplegia.	2001 Feb	11225579
Allergic contact dermatitis to proparacaine with subsequent cross-sensitization to tetracaine from ophthalmic preparations.	2001 Sep	11526525
Survival of equine herpesvirus-4, feline herpesvirus-1, and feline calicivirus in multidose ophthalmic solutions.	2002 Dec	12445296
Efficacy of sucrose to reduce pain in premature infants during eye examinations for retinopathy of prematurity.	2005 Jun	15855243
Randomised controlled trial of sub-Tenon's block versus topical anaesthesia for cataract surgery: a comparison of patient satisfaction.	2005 Mar	15722306
Anaesthetic abuse keratopathy as a manifestation of ocular Munchausen's syndrome.	2006 Jan-Feb	16451265
Duration of corneal anesthesia following topical administration of 0.5% proparacaine hydrochloride solution in clinically normal cats.	2006 Oct	17014333
An assessment of the discomfort associated with the use of rose bengal 1% eyedrops on the normal human eye: a comparison with saline 0.9% and a topical ocular anaesthetic.	2007 Mar	17324205
Does prior instillation of a topical anaesthetic alter the pupillary mydriasis produced by tropicamide (0.5%)?	2007 May	17470245
Antibacterial activity of preservative-free topical anesthetic drops in current use in ophthalmology departments.	2009 Jan	19092407
Intrathecal oxybuprocaine and proxymetacaine produced potent and long-lasting spinal anesthesia in rats.	2009 May 1	19429093
Effect of topical anesthesia and age on pain scores during retinopathy of prematurity screening.	2010 Nov	20237484

Patents

Sample Use Guides

In Vivo Use Guide

Unknown

Route of Administration: Parenteral

In Vitro Use Guide

Unknown

Substance Class	Chemical Created by `admin` on `Sat Dec 16 16:52:37 GMT 2023` Edited by `admin` on `Sat Dec 16 16:52:37 GMT 2023`
Record UNII	EPD1EH7F53
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

PROPOXYCAINE

Official Name

English

Propoxycaine [WHO-DD]

Common Name

English

propoxycaine [INN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C245